Ticker Symbol: REPH
Recro Pharma Inc
$1.67 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001588972
Company Profile
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.recropharma.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: January 28, 2022 04:00 PM EST
Previous Close: $1.47
Change:
-$0.03
(
-2.00%)
Days Range: $1.42 - $1.48
Beta: 1.46
52wk. High: $5.29
52wk. Low: $1.38
Ytd. Change -14.28%
50 Day Moving Average: $1.62
200 Day Moving Average: $1.88
Shares Outstanding: 46987685
Valuation
Market Cap: 6.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A